Navigation Links
Campbell Alliance Sales Practice to Present at CBI's Leadership Summit on Evolving the Pharma Sales Model
Date:9/5/2008

distinguished himself as a member of Olympus's top sales group. Mr. O'Grady also served as a sales representative for Ciba-Geigy and was a member of Ciba's Circle of Excellence. Mr. O'Grady received his MBA from the University of North Carolina at Chapel Hill and earned his BS from the United States Military Academy, West Point.

Earlier in the day, from 8:30 am to 12:00 pm, Mr. Isaac will present a workshop titled "Optimize the Specialty Sales Model - Leverage Smaller Sales Forces and Align Selling Strategies to Specialty and Hospital Environments." The workshop will examine key components of the specialty sales model, as well as common challenges facing each component and best practices to optimally address them. Mr. Isaac will also discuss current industry trends and resulting implications for future sales force strategy development.

"The truth of the matter is that there is no best specialty sales force model," said Mr. Isaac. "Each sales force is different and faces its own unique challenges. The ability to recognize this and know how to address the various components of each specialty force is key to success in the field."

Mr. Isaac brings to Campbell Alliance more than 11 years of pharmaceutical industry experience, including six years managing sales force automation implementations. Having developed many innovative technical solutions to drive sales and collect market intelligence, Mr. Isaac uses his unique sales experience and skills to serve Campbell Alliance's clients. Mr. Isaac holds an MBA with distinction from New York University's Stern School of Business and a BS in Management Information Systems from Binghamton University.

For more information on CBI's Leadership Summit on Evolving the Pharma Sales Model, please visit http://www.cbinet.com/show_conference.cfm?confCode=PC08057.

Executives from Campbell Alliance speak at many confe
'/>"/>

SOURCE Campbell Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
2. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
3. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
4. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
5. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference
6. Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference
7. Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
8. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
9. Campbell Alliance Managed Markets Practice to Take a Leadership Role at the CBI Forum on Effective Product Pricing and Modeling Strategies
10. Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
11. Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBIs Early Commercialization Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... CINCINNATI , March 26, 2015 ... NASDAQ: SHPG ) and Cincinnati Children,s Hospital ... collaboration for rare diseases. The goal of the collaboration ... treat rare diseases with high unmet medical need ... Children,s research expertise. As a nationally ranked hospital, ...
(Date:3/26/2015)... Ale Gicqueau, Founder and President of Clinovo, ... at Align Technology, on “ Conducting Postmarket Registries - ... Global Conference and Exhibition on April 25th through April ... the poster presentation, Ale Gicqueau and Victor Chen will ... Registry, the requirements and resources to conduct the registry, ...
(Date:3/25/2015)... March 25, 2015 Optimal Research, LLC has ... Excellence (ViE) Award "Best Clinical Site or Trial Network". ... Optimal has been selected as a nominee in this ... a "Highly Recommended" distinction in 2014. The ViE awards ... efforts, accomplishments, and positive contributions of companies and individuals ...
(Date:3/25/2015)... and REYKJAVIK, Iceland , March 25, 2015 ... the genome to create better medicine, today congratulated the scientists ... of whole-genome data yet undertaken. The studies ... – are built around the most comprehensive population-wide tally ... deCODE scientists led by Kari Stefansson , deCODE,s founder ...
Breaking Biology Technology:Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 2Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 3Optimal Research Nominated 2015 Vaccine Industry Excellence (ViE) Award 2Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2
... , , SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: ... quarter ended September 30, 2009. For the three months ended September ... $1.34 per share, as compared to a net loss of $7.4 ... For the nine months ended September 30, 2009, the Company reported ...
... MALVERN, Pa. and WALTHAM, Mass., Nov. 19 Arlington ... leading driver of antibiotic selection in nosocomial pneumonia in ... Due to the variety of organisms that can cause ... primarily for agents that provide appropriate coverage against common ...
... ... aid. , ... CA (PRWEB) November 16, 2009 -- Popular Science Magazine has named the Lyric “invisible” ... Award in the Health category.    Chosen from thousands of entrants, Lyric is designed to reside ...
Cached Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
(Date:3/10/2015)... 10, 2015  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing ... wallet has been named the "Number One Best ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a ... home and lifestyle that have a unique function or ...
(Date:3/2/2015)... Calif. , March 2, 2015 ... leading developer of human interface solutions, today announced ... that is designed to enable rapid and secure ... ID™ module for gaming is a turnkey solution ... the ability to quickly integrate fingerprint ID solutions ...
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11
... heterococcus sp. DN1 , which may prove ... in the snow fields of the Rocky Mountains. Research examining ... H. sp. DN1 was found to grow at temperatures ... H. sp. DN1 produces the highest quantity of ...
... in families, researchers at Johns Hopkins have found that ... team up to increase the risk of schizophrenia. They ... Psychiatry , bring some clarity to the murky relationship ... genetic test that can predict which medications will be ...
... in an experiment conducted at the University of Wisconsin-Madison ... model ALS, a nerve disease that destroys nerve control ... (amyotrophic lateral sclerosis) is sometimes called "Lou Gehrig,s disease." ... 5,600 Americans each year. Only about half of patients ...
Cached Biology News:Family studies suggest rare genetic mutations team up to cause schizophrenia 2Engineered stem cell advance points toward treatment for ALS 2Engineered stem cell advance points toward treatment for ALS 3
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
11-keto Testosterone EIA Antiserum hormones steroids antisera antiserum eias enzyme immunoassays reagents 11-keto-testosterone...
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID: ...
Biology Products: